Nanologistics UAB is a Lithuanian biotech startup specialising in the development of advanced liposomal drug delivery systems designed to enhance the absorption of drugs and reduce side effects. As a Contract Research Organisation (CRO) and manufacturer, the company focuses on providing innovative carriers that ensure the safe and precise delivery of complex molecules. Supported by state funding and in partnership with Vytautas Magnus University, Nanologistics UAB is committed to advancing bioavailability and therapeutic outcomes through cutting-edge CRO services. With a dedicated team of experts, the company is driving innovation in biotechnology and is actively seeking partnerships to further health and wellness solutions.

Services include:
- Anatomical Therapeutic Chemical (ATC) Classification
- Contract Research
- Liposomal formulation development
- Drug delivery systems design
- Bioavailability studies
- Toxicology assessments

Nanologistics UAB continues to lead in the biotechnology sector, providing essential services to the pharmaceutical industry. For more information, visit nanologistics.lt.